New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif

about

New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif

Item

http://www.wikidata.org/entity/Q57822389

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 10 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@en

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@nl

type

Item

label

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@en

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@nl

prefLabel

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@en

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@nl

P1476

New Dopamine D3-Selective Rece ...... trahydroisoquinolin-7-ol Motif

@en

P2093

Lauren Wickstrom

http://www.w3.org/2001/XMLSchema#string

Pierpaolo Cordone

http://www.w3.org/2001/XMLSchema#string

Rajat K Pal

http://www.w3.org/2001/XMLSchema#string

Satishkumar Gadhiya

http://www.w3.org/2001/XMLSchema#string

Steven Ramsey

http://www.w3.org/2001/XMLSchema#string

Tom Kurtzman

http://www.w3.org/2001/XMLSchema#string

P2860

N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction

Integrated Modeling Program, Applied Chemical Theory (IMPACT)

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Dopamine: a key regulator to adapt action, emotion, motivation and cognition.

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.

Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.

Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.

P304

990-995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.8B00229

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emilio Gallicchio

Wayne W Harding

P577

2018-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30344905

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

P932

6187407

http://www.w3.org/2001/XMLSchema#string